JOURNAL OF HEART AND LUNG TRANSPLANTATION

Scope & Guideline

Pioneering Innovations in Transplantation and Cardiovascular Care

Introduction

Immerse yourself in the scholarly insights of JOURNAL OF HEART AND LUNG TRANSPLANTATION with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN1053-2498
PublisherELSEVIER SCIENCE INC
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 1991 to 2024
AbbreviationJ HEART LUNG TRANSPL / J. Heart Lung Transplant.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressSTE 800, 230 PARK AVE, NEW YORK, NY 10169

Aims and Scopes

The Journal of Heart and Lung Transplantation focuses on advancing the science and practice of organ transplantation, particularly concerning heart and lung procedures. It aims to disseminate groundbreaking research, clinical experiences, and consensus guidelines that shape the future of transplantation practices.
  1. Clinical Outcomes and Patient Management:
    The journal emphasizes studies related to clinical outcomes in heart and lung transplant recipients, focusing on patient management strategies, post-operative care, and long-term follow-up.
  2. Innovative Transplant Techniques and Technologies:
    It highlights advancements in surgical techniques, mechanical circulatory support devices, and organ preservation technologies, showcasing how these innovations improve transplantation success.
  3. Immunology and Rejection Mechanisms:
    Research related to immune responses, including antibody-mediated rejection and the role of different immunosuppressive therapies, is a core focus, exploring how these factors influence graft survival.
  4. Socioeconomic and Racial Disparities:
    The journal addresses disparities in transplantation outcomes based on socioeconomic status and race, aiming to bring attention to inequalities in access to transplant services.
  5. Emerging Therapies and Biomarkers:
    It includes studies on new therapeutic approaches, biomarker identification for predicting rejection, and monitoring graft health, contributing to personalized medicine in transplantation.
The Journal of Heart and Lung Transplantation has been at the forefront of several emerging themes that reflect the current trends in transplantation science and practice. These trends highlight the journal's commitment to addressing contemporary challenges and innovations in the field.
  1. Donor-Derived Cell-Free DNA Monitoring:
    The use of donor-derived cell-free DNA as a biomarker for graft health and rejection surveillance has gained prominence, reflecting an increasing interest in non-invasive monitoring techniques.
  2. Telehealth and Remote Monitoring:
    With the rise of digital health, studies exploring telehealth applications for monitoring transplant recipients and improving patient engagement are trending, particularly in the context of the COVID-19 pandemic.
  3. Holistic Approaches to Patient Care:
    There is a growing emphasis on the psychosocial aspects of transplantation, including caregiver support, mental health interventions, and quality of life assessments for patients.
  4. Personalized Medicine in Transplantation:
    Research focused on tailoring immunosuppressive therapies based on individual patient and donor characteristics is emerging as a crucial area, promoting better outcomes.
  5. Integration of Machine Learning and AI in Transplantation:
    The application of machine learning models to predict transplant outcomes and assess risk factors is becoming increasingly popular, facilitating data-driven decision-making in clinical practice.

Declining or Waning

As the field of organ transplantation evolves, certain themes within the Journal of Heart and Lung Transplantation have shown a decline in focus. This could reflect shifts in clinical priorities, research funding, or advancements in technology that render previously critical areas less prominent.
  1. Traditional Immunosuppression Protocols:
    There is a noticeable decrease in studies focused solely on traditional immunosuppressive regimens, as newer therapies and personalized approaches gain traction.
  2. Longitudinal Studies on Aging Donor Organs:
    Research centered on the aging of donor organs and its effects on transplantation outcomes appears to be waning, possibly overshadowed by advancements in organ preservation and procurement techniques.
  3. Basic Science Studies on Transplant Immunology:
    While fundamental research remains important, there has been a shift towards clinical applications and practical outcomes, resulting in fewer basic science studies being published.
  4. Single-Center Studies:
    As multicenter collaborations become more common, the focus on single-center studies is declining, likely due to the need for broader data to support findings.
  5. Historical Case Studies and Anecdotal Evidence:
    The journal has seen a reduction in the publication of historical case studies as the focus shifts to evidence-based practices and current clinical guidelines.

Similar Journals

Transplantation and Cellular Therapy

Connecting Science and Practice in Transplantation and Immunology.
Publisher: ELSEVIER SCIENCE INCISSN: 2666-6375Frequency: 12 issues/year

Transplantation and Cellular Therapy is a leading journal published by Elsevier Science Inc, dedicated to advancing the fields of transplantation, immunology, cell biology, and molecular medicine. With its ISSN of 2666-6375 and E-ISSN 2666-6367, this journal serves as a vital resource for researchers, practitioners, and students aiming to stay at the forefront of innovative therapies and clinical practices in transplantation. As of 2023, it holds an impressive Q1 ranking in multiple categories, including Cell Biology, Hematology, Immunology and Allergy, Molecular Medicine, and Transplantation, reflecting its high impact and relevance in the scientific community. The journal, operating from its base in the Netherlands, supports Open Access publishing to enhance the dissemination and accessibility of groundbreaking research. Acknowledging the significance of transplantation and cellular therapies in modern medicine, Transplantation and Cellular Therapy is poised to propel future discoveries and developments in these critical domains.

LUNG

Connecting researchers and clinicians in the fight against lung diseases.
Publisher: SPRINGERISSN: 0341-2040Frequency: 6 issues/year

LUNG is a prestigious academic journal that has been a cornerstone in the field of Pulmonary and Respiratory Medicine since its inception in 1959. Published by SPRINGER, the journal holds an impressive Q1 ranking in its category for 2023, reflecting its commitment to disseminating high-quality research and advancing clinical practices in respiratory health. With a Scopus rank of 24 out of 155 in its field, representing the top 16% of journals, LUNG continues to serve as a vital platform for researchers, clinicians, and students who are dedicated to addressing the complexities of lung diseases. Although currently not an open-access journal, LUNG offers valuable insights and significant contributions to the understanding of respiratory conditions, ensuring that its readership stays at the forefront of medical advancements. Researchers and professionals are encouraged to submit their work and engage with a thriving academic community that is passionate about improving patient outcomes in pulmonary health.

Journal of Transplantation

Advancing the Frontiers of Organ Transplantation
Publisher: HINDAWI LTDISSN: 2090-0007Frequency: 1 issue/year

The Journal of Transplantation is a leading peer-reviewed journal published by HINDAWI LTD, dedicated to advancing the field of organ transplantation and associated medical research. Since its inception in 2009 as an Open Access journal, it has provided a vital platform for researchers, clinicians, and students to share innovative findings and developments in transplantation science. With an emphasis on high-quality research, the journal aims to publish original articles, reviews, and case studies that contribute to the understanding of immunology, surgical techniques, and postoperative care, thereby enhancing patient outcomes. The journal is committed to fostering a collaborative scientific community and making valuable research freely accessible to professionals worldwide, ensuring that it remains at the forefront of transplantation studies. This journal serves as an essential resource for anyone looking to stay updated on the latest advancements and clinical practices in the field.

AMERICAN JOURNAL OF TRANSPLANTATION

Advancing transplantation science for a healthier tomorrow.
Publisher: ELSEVIER SCIENCE INCISSN: 1600-6135Frequency: 12 issues/year

American Journal of Transplantation, published by Elsevier Science Inc, is a premier academic journal dedicated to the critical field of transplantation. With an impressive impact factor and prestigious rankings in Immunology and Allergy, Pharmacology (medical), and Transplantation, it stands as a leading source of high-quality research in these domains, boasting a Q1 category status since 2023. The journal serves an essential role in advancing scientific knowledge and clinical practices, publishing cutting-edge studies that address pressing issues in organ transplantation and immunology. Researchers, healthcare professionals, and students will find valuable insights through rigorous peer-reviewed articles that focus on innovative methodologies, outcomes, and the latest developments within transplantation science. As the journal continues to evolve from its inception in 2001 to its ongoing contributions through 2024, it remains a key resource for those looking to stay at the forefront of transplantation research and practice.

Expert Review of Respiratory Medicine

Exploring the Frontiers of Pulmonary Health
Publisher: TAYLOR & FRANCIS LTDISSN: 1747-6348Frequency: 6 issues/year

Expert Review of Respiratory Medicine is a leading journal published by Taylor & Francis Ltd, dedicated to advancing the field of respiratory medicine through evidence-based research and comprehensive reviews. With a robust ISSN of 1747-6348 and an E-ISSN of 1747-6356, the journal disseminates essential insights into pulmonary and respiratory health, ranking an impressive #33 in Medicine - Pulmonary and Respiratory Medicine on Scopus, reflecting its significant contribution to this discipline. Established in 2007 and extending its reach through 2024, Expert Review of Respiratory Medicine serves as a crucial resource for professionals and researchers dedicated to improving respiratory health outcomes. Though not designated as an open-access journal, its impactful articles are pivotal in shaping clinical practices and guiding future research in respiratory medicine and related fields, including public health and immunology. By engaging with this journal, readers can stay abreast of the latest developments and critically evaluate advancements in respiratory care.

Current Transplantation Reports

Bridging Research and Clinical Excellence in Transplantation
Publisher: SPRINGERNATUREISSN: Frequency: 4 issues/year

Current Transplantation Reports, published by SpringerNature, is a leading journal in the field of transplantation science, offering vital insights into the cutting-edge developments in transplant medicine and related disciplines. With an impressive array of quartile rankings, including Q2 in Nephrology and Transplantation, and Q3 in Hepatology and Immunology for 2023, this journal plays a significant role in bridging research and clinical practice. Focused on fostering innovation, the journal spans a wide spectrum of topics, from surgical advances to immunological considerations of transplant procedures. It serves as an invaluable resource for researchers, healthcare professionals, and students interested in the latest advancements and data in transplantation, recognizing the importance of disseminating knowledge in this evolving field. Although currently not designated as Open Access, it provides rigorous peer-reviewed articles that contribute to the academic community's understanding of transplantation scenarios and challenges faced in clinical settings.

Indian Journal of Transplantation

Pioneering Research in Transplant Medicine
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 2212-0017Frequency: 4 issues/year

Indian Journal of Transplantation (ISSN: 2212-0017, E-ISSN: 2212-0025), published by Wolters Kluwer Medknow Publications, serves as a pivotal resource in the expanding field of transplantation medicine. As an Open Access journal since 2011, it provides unrestricted access to cutting-edge research, facilitating the dissemination of knowledge among practitioners, researchers, and students globally. With a growing focus on transplant-related advancements from 2020 to 2024, the journal has positioned itself within the Q4 category in Transplantation, underscoring its commitment to publishing valuable contributions that aim to enhance clinical practices and improve patient outcomes. Situated in the Netherlands, the journal upholds high-quality standards, inviting submissions that contribute to the understanding of various transplant procedures and practices, ultimately fostering innovation in the field. Researchers and professionals are encouraged to explore the vast array of articles, enhancing both their expertise and the community's collective knowledge in transplantation.

Annals of Transplantation

Elevating Standards in Transplantation Practices
Publisher: INT SCIENTIFIC INFORMATION, INCISSN: 1425-9524Frequency: 1 issue/year

Annals of Transplantation is a renowned academic journal published by INT SCIENTIFIC INFORMATION, INC, dedicated to the field of transplantation medicine. With a strong historical presence since its inception in 1996, this journal continues to provide a vital platform for disseminating innovative research, clinical studies, and review articles that contribute significantly to the ever-evolving landscape of organ transplantation. Holding a respectable Q2 ranking in the field of transplantation and a Q3 ranking in broader medicine categories as of 2023, the journal stands out with an impactful repository of knowledge that caters to a diverse audience, including researchers, healthcare professionals, and students. While it currently does not operate under an open access model, the scholarly contributions within are crucial for advancing practices, policies, and outcomes in transplantation. Whether you are seeking to keep abreast of recent advances or looking to publish your own findings, Annals of Transplantation serves as an essential resource for fostering collaboration and innovation in medical science.

Vestnik Transplantologii i Iskusstvennyh Organov

Transforming the landscape of organ transplantation research.
Publisher: FEDERAL RESEARCH CENTER TRANSPLANTOLOGY & ARTIFICIAL ORGANS V I SHUMAKOVISSN: 1995-1191Frequency: 4 issues/year

Vestnik Transplantologii i Iskusstvennyh Organov, published by the Federal Research Center Transplantology & Artificial Organs V I Shumakov, is an esteemed open access journal that has been disseminating critical research in the fields of transplantation and immunology since 2009. With an ISSN of 1995-1191 and E-ISSN 2412-6160, this journal serves as a vital resource for academics and practitioners alike, offering insights into current trends, innovations, and methodologies in organ transplantation. The journal is indexed in prominent databases, holding a Q4 category in Immunology and Allergy and a Q3 in Transplantation as of 2023, ranking 42nd out of 54 in the field of Medicine - Transplantation, and 208th out of 233 in Medicine - Immunology and Allergy. Through its commitment to open access publishing and its strategic focus on advancing the science of transplantology, Vestnik Transplantologii i Iskusstvennyh Organov contributes significantly to the global body of knowledge, promoting collaboration and engagement among researchers, healthcare professionals, and students from around the world.

LIVER TRANSPLANTATION

Shaping the Future of Transplantation through Cutting-edge Research.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 1527-6465Frequency: 12 issues/year

LIVER TRANSPLANTATION, published by Lippincott Williams & Wilkins, stands at the forefront of hepatology and transplantation research, with a prestigious Q1 rating across the categories of Hepatology, Surgery, and Transplantation as of 2023. Since its inception in 2000, this journal has been dedicated to disseminating high-quality, cutting-edge research that advances the understanding and practice of liver transplantation. With an impressive ranking of 23rd out of 551 in Surgery and 9th out of 54 in Transplantation, it occupies an esteemed position in the academic landscape, attracting contributions from leading experts in the field. The journal's rigorous peer-review process ensures the publication of impactful studies, innovative clinical practices, and vital insights into patient management. By fostering a collaborative environment for researchers, clinicians, and students alike, LIVER TRANSPLANTATION serves as an essential resource for those engaged in the complexities of liver transplantation and related fields. Join the community committed to advancing liver health and transplantation science.